Oral Ondansetron in the Prevention of Chemotherapy-induced Emesis in Breast Cancer Patients

By Clavel M.   Bonneterre J.   d'Allens H.   Paillarse J.-M.  

European Journal of Cancer, Vol. 31, Iss. 1, 1995-01 ,pp. : 15-19

Elsevier

Access to resources Recommend Favorite

Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in patients with cancer

By Navari Rudolph M  

Future Oncology, Vol. 6, Iss. 7, 2010-07 ,pp. : 1073-1084

Future Medicine

Access to resources Recommend Favorite

Oral Glutamine in the Prevention of Chemotherapy-induced Gastrointestinal Toxicity

By Muscaritoli M.   Micozzi A.   Conversano L.   Martino P.   Petti M.C.   Cartoni C.   Cascino A.   Rossi-Fanelli F.  

European Journal of Cancer, Vol. 33, Iss. 2, 1997-02 ,pp. : 319-320

Elsevier

Access to resources Recommend Favorite

The development and validation of a prediction tool for chemotherapy-induced anemia in patients with advanced nonsmall cell lung cancer receiving palliative chemotherapy

By Vincent Mark   Dranitsaris George   Verma Sunil   Lau Cathy   Gascon Pere   Belle Simon   Ludwig Heinz  

Supportive Care in Cancer, Vol. 15, Iss. 3, 2007-03 ,pp. : 265-272

Springer Publishing Company

Access to resources Recommend Favorite

Effectiveness of palonosetron for preventing delayed chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy in patients with gastrointestinal cancer

By Murakami Michiyasu   Hashimoto Hiroki   Yamaguchi Kyohei   Yamaguchi Ikuko   Senba Shozo   Siraishi Takeshi  

Supportive Care in Cancer, Vol. 22, Iss. 4, 2014-04 ,pp. : 905-909

Springer Publishing Company

Access to resources Recommend Favorite